Outcomes among older adult liver transplantation recipients in the model of end stage liver disease (meld) era

Annals of Transplantation

Volumn 19, Issue 1, 2014, Pages 478-487

  Malinis, Maricar F ^a   Chen, Shu ^a   Allore, Heather G ^a   Quagliarello, Vincent J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age groups; Liver transplantation; Patient outcome assessment

Indexed keywords

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BILIARY TRACT DISEASE; COHORT ANALYSIS; DAILY LIFE ACTIVITY; DEATH; DIALYSIS; END STAGE LIVER DISEASE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS; HEPATITIS C; HISTORICAL PERIOD; HUMAN; INFECTION; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SEPSIS; THROMBOSIS; UNIVARIATE ANALYSIS; AGE; EPIDEMIOLOGY; PATIENT SELECTION; TRANSPLANTATION; TREATMENT OUTCOME; UNITED STATES;

AGE FACTORS; AGED; COHORT STUDIES; END STAGE LIVER DISEASE; FEMALE; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; UNITED STATES;

EID: 84919639291     PISSN: 14259524     EISSN: None     Source Type: Journal    
DOI: 10.12659/AOT.890934     Document Type: Article

References (56)

1. Aduen JF, Sujay B, Dickson RC et al: Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years. Mayo Clin Proc, 2009; 84(11): 973–78
2. Emre S, Mor E, Schwartz ME et al: Liver transplantation in patients beyond age 60. Transplant Proc, 1993; 25(1 Pt 2): 1075–76
3. Pirsch JD, Kalayoglu M, D’Alessandro AM et al: Orthotopic liver transplantation in patients 60 years of age and older. Transplantation, 1991; 51(2): 431–33
4. Stieber AC, Gordon RD, Todo S et al: Liver transplantation in patients over sixty years of age. Transplantation, 1991; 51(1): 271–73
5. Audet M, Piardi T, Panaro F et al: Liver transplantation in recipients over 65 yr old: a single center experience. Clin Transplant, 2010; 24(1): 84–90
6. Bilbao I, Dopazo C, Lazaro JL et al: Our experience in liver transplantation in patients over 65 yr of age. Clin Transplant, 2008; 22(1): 82–88
7. Kemmer N, Safdar K, Kaiser TE et al: Liver transplantation trends for older recipients: regional and ethnic variations. Transplantation, 2008; 86(1): 104–7
8. Safdar K, Nef GW, Montalbano M et al: Liver transplant for the septuagenarians: importance of patient selection. Transplant Proc, 2004; 36(5): 1445–48
9. Zetterman RK, Belle SH, Hoofnagle JH et al: Age and liver transplantation: a report of the Liver Transplantation Database. Transplantation, 1998; 66(4): 500–6
10. Levy MF, Somasundar PS, Jennings LW et al: The elderly liver transplant recipient: a call for caution. Ann Surg, 2001; 233(1): 107–13
11. Herrero JI, Lucena JF, Quiroga J et al: Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy. Am J Transplant, 2003; 3(11): 1407–12
12. Busuttil RW, Farmer DG, Yersiz H et al: Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg, 2005; 241(6): 905–16; discussion 916–18
13. Freeman RB, Wiesner RH, Edwards E et al: Results of the first year of the new liver allocation plan. Liver Transpl, 2004; 10(1): 7–15
14. Kanwal F, Dulai GS, Spiegel BM et al: A comparison of liver transplantation outcomes in the pre- vs. post-MELD eras. Aliment Pharmacol Ther, 2005; 21(2): 169–77
15. Dellon ES, Galanko JA, Medapalli RK, Russo MW: Impact of dialysis and older age on survival after liver transplantation. Am J Transplant, 2006; 6(9): 2183–90
16. OPTN/SRTR 2011 Annual Data Report: Liver. Available from: http://srtr.trans-plant.hrsa.gov/annual_reports/2011/pdf/03_ liver_12.pdf
17. Smith BD, Morgan RL, Beckett GA et al: Recommendations for the identi-fcation of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR Recomm Rep, 2012; 61(RR-4):1–32. Erratum in: MMWR Recomm Rep, 2012; 61(43): 886
18. Feng S, Goodrich NP, Bragg-Gresham JL et al: Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant, 2006; 6(4): 783–90
19. Yates JW, Chalmer B, McKegney FP: Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer, 1980; 45(8): 2220–24
20. Crooks V, Waller S, Smith T, Hahn TJ: The use of the Karnofsky Performance Scale in determining outcomes and risk in geriatric outpatients. J Gerontol, 1991; 46(4): M139–44
21. Randall HB, Cao S, deVera ME: Transplantation in elderly patients. Arch Surg, 2003; 138(10): 1089–92
22. Licastro F, Candore G, Lio D et al: Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing, 2005; 2: 8
23. Martins PN, Pratschke J, Pascher A et al: Age and immune response in organ transplantation. Transplantation, 2005; 79(2): 127–32
24. Meier-Kriesche HU, Ojo A, Hanson J et al: Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation, 2000; 69(5): 885–89
25. Singh N, Gayowski T, Wagener MM, Marino IR: Quality of life, functional status, and depression in male liver transplant recipients with recurrent viral hepatitis C. Transplantation, 1999; 67(1): 69–72
26. Gane E: The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients. Liver Transpl, 2003; 9(11): S28–34
27. Berenguer M, Ferrell L, Watson J et al: HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol, 2000; 32(4): 673–84
28. Forns X, Garcia-Retortillo M, Serrano T et al: Antiviral therapy of patients with decompensated cirrhosis to prevent recurrence of hepatitis C after liver transplantation. J Hepatol, 2003; 39(3): 389–96
29. Honda T, Katano Y, Shimizu J et al: Efficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C. Liver Int, 2010; 30(4): 527–37
30. Hu CC, Lin CL, Kuo YL et al: Efficacy and safety of ribavirin plus pegylat-ed interferon alfa in geriatric patients with chronic hepatitis C. Aliment Pharmacol Ther, 2013; 37(1): 81–90
31. AASLD and IDSA Recommendations for Testing, Managing and Treating Hepatitis C 2014. Available from: http://www.hcvguidelines.org
32. Grat M, Kornasiewicz O, Lewandowski Z et al: Post-transplant outcomes of patients with and without hepatitis C virus infection according to donor age and gender matching. Ann Transplant, 2013; 18: 705–15
33. Volk ML, Reichert HA, Lok AS, Hayward RA: Variation in organ quality between liver transplant centers. Am J Transplant, 2011; 11(5): 958–64
34. Schrem H, Reichert B, Fruhauf N et al: The Donor-Risk-Index, ECD-Score and D-MELD-Score all fail to predict short-term outcome after liver transplantation with acceptable sensitivity and specificity. Ann Transplant, 2012; 17(3): 5–13
35. Reichert B, Becker T, Weismuller TJ et al: Value of the preoperative SOFT-score, P-SOFT-score, SALT-score and labMELD-score for the prediction of short-term patient and graft survival of high-risk liver transplant recipients with a pre-transplant lab MELD-score ≥30. Ann Transplant, 2012; 17(2): 11–17
36. Bonney GK, Aldersley MA, Asthana S et al: Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience. Transplantation, 2009; 87(12): 1858–63
37. Avolio AW, Siciliano M, Barbarino R et al: Donor risk index and organ patient index as predictors of graft survival after liver transplantation. Transplant Proc, 2008; 40(6): 1899–902
38. Alkofer B, Samstein B, Guarrera JV et al: Extended-donor criteria liver al-lografts. Semin Liver Dis, 2006; 26(3): 221–33
39. Mahrouf-Yorgov M, de L’hortet A C, Cosson C et al: Increased susceptibility to liver fbrosis with age is correlated with an altered inflammatory response. Rejuvenation Res, 2011; 14(4): 353–63
40. Tsukamoto I, Nakata R, Kojo S: Effect of ageing on rat liver regeneration after partial hepatectomy. Biochem Mol Biol Int, 1993; 30(4): 773–78
41. Alexander JW, Vaughn WK: The use of “marginal” donors for organ transplantation. The influence of donor age on outcome. Transplantation, 1991; 51(1): 135–41
42. Busquets J, Xiol X, Figueras J et al: The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival. Transplantation, 2001; 71(12): 1765–71
43. Habib S, Berk B, Chang CC et al: MELD and prediction of post-liver transplantation survival. Liver Transpl, 2006; 12(3): 440–47
44. Brown RS Jr, Kumar KS, Russo MW et al: Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl, 2002; 8(3): 278–84
45. Hayashi PH, Forman L, Steinberg T et al: Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl, 2003; 9(7): 737–40
46. Narayanan Menon KV, Nyberg SL, Harmsen WS et al: MELD and other factors associated with survival after liver transplantation. Am J Transplant, 2004; 4(5): 819–25
47. Didsbury M, McGee RG, Tong A et al: Exercise training in solid organ transplant recipients: a systematic review and meta-analysis. Transplantation, 2013; 95(5): 679–87
48. Epstein SK, Freeman RB, Khayat A et al: Aerobic capacity is associated with 100-day outcome after hepatic transplantation. Liver Transpl, 2004; 10(3): 418–24
49. Rubenstein LZ, Schairer C, Wieland GD, Kane R: Systematic Biases in Functional Status Assessment of Elderly Adults: Effects of Different Data Sources. J Gerontol, 1984; 39(6): 686–91
50. Abecassis M, Bridges ND, Clancy CJ et al: Solid-Organ Transplantation in Older Adults: Current Status and Future Research. Am J Transplant, 2012; 12(10): 2608–22
51. Inouye SK, Peduzzi PN, Robison JT et al: Importance of functional measures in predicting mortality among older hospitalized patients. JAMA, 1998; 279(15): 1187–93
52. Rumsfeld JS, MaWhinney S, McCarthy M Jr et al: Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. Participants of the Department of Veterans Afairs Cooperative Study Group on Processes, Structures, and Outcomes of Care in Cardiac Surgery. JAMA, 1999; 281(14): 1298–303
53. Jacob M, Copley LP, Lewsey JD et al: Functional status of patients before liver transplantation as a predictor of posttransplant mortality. Transplantation, 2005; 80(1): 52–57
54. Larbi A, Franceschi C, Mazzatti D et al: Aging of the immune system as a prognostic factor for human longevity. Physiology (Bethesda), 2008; 23: 64–74
55. Pedersen BK, Hofman-Goetz L: Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev, 2000; 80(3): 1055–81
56. Berry SD, Ngo L, Samelson EJ, Kiel DP: Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc, 2010; 58(4): 783–87